Artigo Revisado por pares

REJECTION OF CANCER HOMOTRANSPLANTS BY PATIENTS WITH DEBILITATING NON‐NEOPLASTIC DISEASES*

1964; Wiley; Volume: 120; Issue: 1 Linguagem: Inglês

10.1111/j.1749-6632.1964.tb34740.x

ISSN

1749-6632

Autores

A. Levin, Denilson Custodio, Emanuel E. Mandel, Chester M. Southam,

Tópico(s)

Hematopoietic Stem Cell Transplantation

Resumo

Annals of the New York Academy of SciencesVolume 120, Issue 1 p. 410-423 REJECTION OF CANCER HOMOTRANSPLANTS BY PATIENTS WITH DEBILITATING NON-NEOPLASTIC DISEASES* Arthur G. Levin, Arthur G. Levin Sloan-Kettering Institute for Cancer Research, New York, N. Y. and the Jewish Chronic Disease Hospital, Brooklyn, N. Y.Search for more papers by this authorD. B. Custodio, D. B. Custodio Sloan-Kettering Institute for Cancer Research, New York, N. Y. and the Jewish Chronic Disease Hospital, Brooklyn, N. Y.Search for more papers by this authorEmanuel E. Mandel, Emanuel E. Mandel Sloan-Kettering Institute for Cancer Research, New York, N. Y. and the Jewish Chronic Disease Hospital, Brooklyn, N. Y.Search for more papers by this authorChester M. Southam, Chester M. Southam Sloan-Kettering Institute for Cancer Research, New York, N. Y. and the Jewish Chronic Disease Hospital, Brooklyn, N. Y.Search for more papers by this author Arthur G. Levin, Arthur G. Levin Sloan-Kettering Institute for Cancer Research, New York, N. Y. and the Jewish Chronic Disease Hospital, Brooklyn, N. Y.Search for more papers by this authorD. B. Custodio, D. B. Custodio Sloan-Kettering Institute for Cancer Research, New York, N. Y. and the Jewish Chronic Disease Hospital, Brooklyn, N. Y.Search for more papers by this authorEmanuel E. Mandel, Emanuel E. Mandel Sloan-Kettering Institute for Cancer Research, New York, N. Y. and the Jewish Chronic Disease Hospital, Brooklyn, N. Y.Search for more papers by this authorChester M. Southam, Chester M. Southam Sloan-Kettering Institute for Cancer Research, New York, N. Y. and the Jewish Chronic Disease Hospital, Brooklyn, N. Y.Search for more papers by this author First published: November 1964 https://doi.org/10.1111/j.1749-6632.1964.tb34740.xCitations: 22 * These studies were supported, in part, by grants from the American Cancer Society and the National Cancer Institute, U. S. Public Health Service. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Southam, C. M., A. E. Moore & C. P. Rhoads. 1957. Homotransplantation of human cell lines. Science 125: 158. 2 Southam, C. M. & A. E. Moore. 1958. Induced immunity to cancer cell homografts in man. Ann. N. Y. Acad. Sci. 73: 635. 3 Southam, C. M., A. Brunschwig & Q. Dizon. 1962. Autologous and homologous transplantation of human cancer. In Biological Interactions in Normal and Neoplastic Growth (Henry Ford Hospital International Symposium): 723–738. Little, Brown & Co. Boston , Mass. 4 Koike, A., G. E. Moore, C. B. Mendoza, Jr. & A. L. Watne. 1963. Heterologous, homologous, and autologous transplantation of human tumors. Cancer 16: 1065. 5 Moore, A. E., L. Sabachewsky & H. W. Toolan. 1955. Culture characteristics of four permanent lines of human cancer cells. Cancer Res. 15: 598. 6 Moore, G. E. & A. Koike. 1964. Growth of human cells in vitro and in vivo. Cancer 17: 11. 7 Karnofsky, D. A. & J. H. Burchenal. 1949. Clinical evaluation of chemotherapeutic agents in cancer, In Evaluation of Chemotherapeutic Agents: 191–205. Columbia Univ. Press, New York , N. Y. 8 Aizawa, M. & C. M. Southam. 1960. Serum antibodies following homotransplantation of human cancer cells. Ann. N. Y. Acad. Sci. 87: 293. 9 Southam, C. M. & A. E. Moore. 1954. Anti-virus antibody studies following induced infection of man with West Nile, Ilheus, and other viruses. J. Immunol. 72: 446. 10 Southam, C. M. & E. L. Greene. 1958. Clinical application of the hemagglutination inhibition test for West Nile virus antibodies. J. Infect. Diseases 102: 174. 11 Itoh, T. & C. M. Southam. Isoantibodies to human cancer cells in cancer patients following cancer cell homotransplants. (in preparation). 12 Lytton, B. & L. E. Hughes. 1964. Circulating antibody response in malignant disease. Lancet 1: 69. 13 Dizon, Q. & C. M. Southam. 1963. Abnormal cellular response to skin abrasion in cancer patients. Cancer 16: 1288. 14 Levin, A. G., E. F. McDonough, Jr., D. Miller & C. M. Southam. 1964. Sensitization to DNFB and its relation to human cancer homotransplant rejection. Ann. N. Y. Acad. Sci. This Annal. Citing Literature Volume120, Issue1Sixth International Transplantation Conference: Part INovember 1964Pages 410-423 ReferencesRelatedInformation

Referência(s)